Swedish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Chosa Oncology

Market Cap: SEK 34.4m

Develops oncology drugs for the treatment of cancer.

AcuCort

Market Cap: SEK 170.7m

Develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.

Annexin Pharmaceuticals

Market Cap: SEK 197.7m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.

Vicore Pharma Holding

Market Cap: SEK 2.8b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

Saniona

Market Cap: SEK 1.6b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

Elicera Therapeutics

Market Cap: SEK 233.0m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Karolinska Development

Market Cap: SEK 242.8m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

Camurus

Market Cap: SEK 39.6b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Abera Bioscience

Market Cap: SEK 105.2m

A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.

Aptahem

Market Cap: SEK 22.8m

A biotechnology company, develops and sells aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions.

Dextech Medical

Market Cap: SEK 132.2m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.

Flerie

Market Cap: SEK 3.3b

A venture capital firm specializing in early-stage investments.

Bonesupport Holding

Market Cap: SEK 18.9b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Spermosens

Market Cap: SEK 24.1m

Provides diagnostic health care products and services in Sweden.

IDL Diagnostics

Market Cap: SEK 92.8m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

Genovis AB (publ.)

Market Cap: SEK 1.5b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

BioArctic

Market Cap: SEK 25.8b

Develops biological drugs for patients with central nervous system disorders in Sweden.

BioInvent International

Market Cap: SEK 2.0b

A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

BioGaia

Market Cap: SEK 11.1b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Promimic

Market Cap: SEK 313.6m

Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.

Infant Bacterial Therapeutics

Market Cap: SEK 937.6m

Operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden.

Dicot Pharma

Market Cap: SEK 1.7b

Engages in the development of pharmaceutical products in Sweden.

Cinclus Pharma Holding

Market Cap: SEK 757.6m

A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.

Biosergen

Market Cap: SEK 123.0m

A biotech company, develops antifungal products.

Isofol Medical

Market Cap: SEK 223.5m

Operates as a clinical stage biotech company.

Intervacc

Market Cap: SEK 349.0m

Develops novel veterinary vaccines for animals in Sweden.

AlzeCure Pharma

Market Cap: SEK 303.4m

Operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

MedCap

Market Cap: SEK 8.3b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.

Newbury Pharmaceuticals

Market Cap: SEK 75.4m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

Respiratorius

Market Cap: SEK 39.4m

A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.

SenzaGen

Market Cap: SEK 185.3m

Provides non-animal tests for assessing allergenicity.

Devyser Diagnostics

Market Cap: SEK 2.3b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Cessatech

Market Cap: DKK 198.0m

A pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark.

Diamyd Medical

Market Cap: SEK 1.5b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

OncoZenge

Market Cap: SEK 78.7m

A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.